ScopeAneurin Bevan University Health Board
91 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Cellular Pathology Department, Royal Gwent Hospital, Cardiff Road
Newport NP20 2UB , United Kingdom
Newport NP20 2UB , United Kingdom
Accreditation
Active
UKAS
10338
wales.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
10338
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (91)
| Standard Reference | Description | Category |
|---|---|---|
| Squamous Cell Carcinoma | Squamous-cell-carcinoma | Clinical Chemistry |
| Bacteria | Bacteria | Clinical Microbiology |
| MEASUREMENT | Measurement | Electrical |
| HELICOBACTER PYLORI | Helicobacter pylori | Food Safety Testing |
| Nuclear protein in lung and thyroid | Thyroid Transcription Factor-1 | Nuclear protein in lung and thyroid | Thyroid Transcription Factor-1 | Histopathology / Cytology |
| Acid and Neutral | Acid and neutral | Other |
| B-cell lymphomas | B-cell lymphomas | Other |
| Breast and urothelial carcinoma | Breast and urothelial carcinoma | Other |
| Breast, lung, gynae adenocarcinoma | Breast, lung, gynae adenocarcinoma | Other |
| CD15 expression in Hodgkin's lymphoma | CD15 expression in Hodgkin's lymphoma | Other |
| Classification of germ cell tumours and GCNIS | Classification of germ cell tumours and GCNIS | Other |
| Classification of lymphomas and carcinomas | Classification of lymphomas and carcinomas | Other |
| Collagen, muscle | Collagen, muscle | Other |
| Colon, rectum, prostate adenocarcinoma | Colon, rectum, prostate adenocarcinoma | Other |
| Colorectal carcinoma | Colorectal carcinoma | Other |
| Cytopathological activities for the purposes of clinical diagnosis | Cytopathological activities for the purposes of clinical diagnosis | Other |
| Demonstration of : Basophilic and eosinophilic structures | Demonstration of: | Operation and Maintenace of | Other |
| Differentiation of ductal (+) carcinoma or breast from lobular (-) | Differentiation of ductal (+) carcinoma or breast from lobular (-) | Other |
| Elastin | Elastin | Other |
| Elastin, Copper associated protein measurement | Elastin, Copper associated protein measurement | Other |
| Endothelial cell marker | Endothelial cell marker | Other |
| Endothelial cells, mesothelioma | Endothelial cells, mesothelioma | Other |
| Epithelial cell marker | Epithelial cell marker | Other |
| Epithelial cell marker measurement | Epithelial cell marker measurement | Other |
| Epithelial marker | Epithelial marker | Other |
| Epithelial marker. Thyroid papillary (+), thyroid follicular (-) | Epithelial marker. Thyroid papillary (+), thyroid follicular (-) | Other |
| Epithelial marker. Urothelial + hepatocellular carcinoma, neuroendocrine tumours, epithelioid malignant mesotheliomas | Epithelial marker. Urothelial + hepatocellular carcinoma, neuroendocrine tumours, epithelioid malignant mesotheliomas | Other |
| Examination of cellular material in order to identify or exclude morphological and cytological abnormalities | Examination of cellular material in order to identify or exclude morphological and cytological abnormalities | Other |
| Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis measurement | Examination of tissues in order to identify or exclude morphological and cytological abnormalities for the purpose of diagnosis measurement | Other |
| Ferric iron, haemosiderin | Ferric iron, haemosiderin | Other |
| Fibrin | Fibrin | Other |
| Fibrohistiocytic marker | Fibrohistiocytic marker | Other |
| Follicular dendritic cell marker | Follicular dendritic cell marker | Other |
| Follicular dendritic cell marker measurement | Follicular dendritic cell marker measurement | Other |
| Gastrointestinal stromal tumour and mast cells | Gastrointestinal stromal tumour and mast cells | Other |
| General B-cell marker | General B-cell marker | Other |
| General lymphoma marker | General lymphoma marker | Other |
| General soft tissue marker | General soft tissue marker | Other |
| Glycogen | Glycogen | Other |
| Glycogen, mucins, BMs and Fungi | Glycogen, mucins, BMs and Fungi | Other |
| Gynae related tumours, renal and thyroid | Gynae related tumours, renal and thyroid | Other |
| HPV related carcinomas | HPV related carcinomas | Other |
| Helper/inducer T cells | Helper/inducer T cells | Other |
| Histopathological Examination activities for the purposes of clinical diagnosis | Histopathological examination activities for the purposes of clinical diagnosis | Other |
| Identification of sodium urate crystals and calcium pyrophosphate crystals | Identification of sodium urate crystals and calcium pyrophosphate crystals | Other |
| Immunohistochemistry examination activities for detection of: ALCL | Immunohistochemistry examination activities for detection of: Epithelial/basal marker | Other |
| Leukocyte Common Antigen | Leukocyte common antigen | Other |
| Low molecular weight cytokeratin marker | Low molecular weight cytokeratin marker | Other |
| Lung and thyroid marker | Lung and thyroid marker | Other |
| Lymphatic endothelial cells | Lymphatic endothelial cells | Other |
| Macrophages | Macrophages | Other |
| Malignant melanoma | Malignant melanoma | Other |
| Malignant mesothelioma, BAP1-deficient melanocytic lesions | Malignant mesothelioma, BAP1-deficient melanocytic lesions | Other |
| Melanin measurement | Melanin measurement | Other |
| Melanoma Marker | Melanoma marker | Other |
| Melanoma and neuroendocrine differentiation | Melanoma and neuroendocrine differentiation | Other |
| Melanoma and normal melanocytes | Melanoma and normal melanocytes | Other |
| Melanoma/metastatic melanoma measurement | Melanoma/metastatic melanoma measurement | Other |
| Mesothelial Cells | Mesothelial Cells | Other |
| Morphological Assessment and Interpretation/Diagnosis | Morphological assessment and interpretation/diagnosis | Other |
| Morphological assessment and interpretation/diagnosis measurement | Morphological assessment and interpretation/diagnosis measurement | Other |
| Mucopolysaccharides | Mucopolysaccharides | Other |
| NK cells, neuroendocrine cells | NK-cells, neuroendocrine cells | Other |
| Neuroendocrine cell marker | Neuroendocrine cell marker | Other |
| Neuroendocrine marker measurement | Neuroendocrine marker measurement | Other |
| Normal lung and lung adenocarcinomas | Normal lung and lung adenocarcinomas | Other |
| Ovarian serous carcinoma, malignant mesothelioma | Ovarian serous carcinoma, malignant mesothelioma | Other |
| P53 expression | P53 expression | Other |
| PROSTATE SPECIFIC ANTIGEN | Prostate specific antigen | Other |
| Plasma cell differentiation | Plasma cell differentiation | Other |
| Preparation of cell blocks followed by subsequent processing, staining and analysis as above measurement | Preparation of cell blocks followed by subsequent processing, staining and analysis as above measurement | Other |
| Prognostic breast cancer marker | Prognostic breast cancer marker | Other |
| Proliferation Marker | Proliferation marker | Other |
| Proliferative zone of epithelium and endothelium. Mantle cell lymphoma | Proliferative zone of epithelium and endothelium. Mantle cell lymphoma | Other |
| Prostate adenocarcinoma | Prostate adenocarcinoma | Other |
| Reed Sternberg cells | Reed-Sternberg cells | Other |
| Retention or loss of MLH1 protein expression in colorectal and endometrial cancers | Retention or loss of MLH1 protein expression in colorectal and endometrial cancers | Other |
| Retention or loss of MSH2 protein expression in colorectal and endometrial cancers | Retention or loss of MSH2 protein expression in colorectal and endometrial cancers | Other |
| Retention or loss of MSH6 protein expression in colorectal and endometrial cancers | Retention or loss of MSH6 protein expression in colorectal and endometrial cancers | Other |
| Retention or loss of PMS2 protein expression in colorectal and endometrial cancers | Retention or loss of PMS2 protein expression in colorectal and endometrial cancers | Other |
| Reticulin Fibres | Reticulin fibres | Other |
| Smooth Muscle | Smooth muscle | Other |
| Smooth muscle and skeletal muscle tumours measurement | Smooth muscle and skeletal muscle tumours measurement | Other |
| Smooth muscle differentiation | Smooth muscle differentiation | Other |
| Squamous differentiation from adenocarcinoma | Squamous differentiation from adenocarcinoma | Other |
| Squamous differentiation from adenocarcinoma measurement | Squamous differentiation from adenocarcinoma measurement | Other |
| Suppressor/cytotoxic T cells | Suppressor/cytotoxic T cells | Other |
| T-Cells, mantle zone B-Cells | T-Cells, mantle zone B-Cells | Other |
| T-cells, sub-set of B cells, classification of lymphomas | T-cells, sub-set of B cells, classification of lymphomas | Other |
| TB | TB | Other |
| Fungi | Fungi | Sterility Testing |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.